UNSPSC 51281658: Neomycin e

This classification denotes an aminoglycoside antibiotic with the molecular formula C23H45N5O14, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 61JJC8N5ZK, chemically known as diamino-2,6-dideoxy-.beta.-l-idopyranosyl-(1->3)-o-.beta.-d-ribofuranosyl-(1->5)-o-(2-amino-2-deoxy-.alpha.-d-glucopyranosyl-(1->4))-2-deoxystreptamine, but more generally known as neomycin e, which bears US NIH Compound Identifier 24176.

European Medicines Agency schedules neomycin e or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03406MIG. Most nations, for tariff purposes, schedule neomycin e under HS 29419000. SMILES: C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)N)O[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O[C@@H]4[C@@H]([C@H]([C@@H]([C@@H](O4)CN)O)O)N)O)O)N.

UNSPSC 51281658 Neomycin e is a Commodity code covering pharmaceutical products acquired by state and local health and public health agencies. The recent opportunities tagged under this code show state and local governments procuring specific pharmaceutical inventory — including antibiotics, opioid-reversal agents, and related medical supplies — through competitive bidding and piggyback procurement vehicles. Work includes warehouse supply contracts for antibiotics and other pharmaceuticals, as well as targeted purchases of naloxone and drug deactivation systems to support public health and community safety initiatives. Issuing bodies soliciting under the code include state health departments and county health and community services authorities, typically working through established cooperative purchasing consortia or direct procurement processes.

Geographic activity centers on Florida and Illinois based on recent opportunities. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical warehouse contract through the MMCAP Infuse consortium to Chartwell Rx LLC on August 28, 2026 (Invitation for Bid 26482DPHPREPDB53392) for Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets under a 12-month initial term with two renewal options. Seminole County, Florida released an Invitation for Bid (IFB60459723LAS) on June 30, 2026 with a July 26, 2023 response deadline seeking annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly delivery to the Seminole County Community Health Building in Sanford, Florida; the contract includes a two-year initial term and one-year renewal option with a three-month probationary period.